PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
Auto Draft
Auto Draft
Elrig
Auto Draft
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Why it is Time to ‘Think Different’ about Nasal Delivery of Biologics

Whether it’s a case of the stars aligning or elements combining, there are plenty of phrases to summarise the power that is unleashed when separate forces unite in a single, shared purpose. These moments of confluence are fertile territory for creativity and innovation. Indeed, as Steve Jobs said, it’s when you connect the dots together that you can “synthesize new things”. Gemma Budd and Irene Rossi at Nanopharm, discuss the reasons why both biologics and nasal delivery are continuing to attract attention. In particular, we will look at the demand for prophylactic therapies to protect populations against the ongoing threat from SARS-CoV-2, and the benefits of targeting these therapies locally in the nasal cavity.

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC